VANGUARD GROUP INC 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-09 10:54 am Sale | 2022-12-30 | 13G | Alaunos Therapeutics, Inc. TCRT | VANGUARD GROUP INC | 60,985 3.810% | -16,573![]() (-21.37%) | Filing |
2022-02-10 08:47 am Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | VANGUARD GROUP INC | 77,558 5.380% | -28,905![]() (-27.15%) | Filing |
2021-02-10 12:04 pm Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | VANGUARD GROUP INC | 106,463 7.450% | 22,496![]() (+26.79%) | Filing |